News from Biocartis A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

06 Dec, 2013, 05:00 ET Biocartis and VIB Join Forces to Develop Unique Diagnostic Cancer Test

Today Biocartis and VIB announced their exclusive license agreement on a novel panel of microsatellite instability (MSI) biomarkers for several...


06 Dec, 2013, 05:00 ET Biocartis et VIB unissent leurs forces pour développer un test de diagnostic du cancer unique

Biocartis et VIB ont annoncé aujourd'hui un accord de licence exclusif concernant un panel de biomarqueurs de l'instabilité...


06 Dec, 2013, 05:00 ET Biocartis en VIB werken samen voor de ontwikkeling van een unieke diagnotische kankertest

Biocartis en VIB kondigen vandaag hun exclusieve licentieovereenkomst aan voor een nieuw panel van biomerkers voor microsatellietinstabiliteit...


05 Nov, 2013, 05:00 ET Biocartis Poised for 2014 Commerical Launch with EUR 30 Million Series E Equity Fundraising

Biocartis, a molecular diagnostics company developing and commercializing innovative, easy to use platforms and clinically relevant...


05 Nov, 2013, 05:00 ET Biocartis in polepositie voor commerciële lancering in 2014 met serie E financiering van 30 miljoen euro

Biocartis, een bedrijf dat actief is in de moleculaire diagnostiek en innovatieve, gebruiksvriendelijke platformen en klinisch relevante testen...


05 Nov, 2013, 05:00 ET Biocartis en mesure de lancer sa commercialisation grâce à une levée de fonds de serie E de 30 millions d'Euros

 L'entreprise de diagnostic moléculaire Biocartis qui développe et commercialise des plateformes innovantes et simples...


17 Oct, 2013, 07:30 ET Biocartis and Hospital del Mar (Barcelona, Spain) Join Forces to Develop Diagnostic Colon Cancer Test

Today Biocartis and Hospital del Mar announced their licence agreement on the EGFR biomarker for colon cancer. This agreement enables...


17 Oct, 2013, 07:30 ET Biocartis et Hospital del Mar (Barcelone, Espagne) unissent leurs forces pour développer un test diagnostique du cancer de l'intestin

Biocartis et Hospital del Mar ont annoncé aujourd'hui un accord de licence autour du biomarqueur EGFR du cancer de l'intestin. Cet accord...


17 Oct, 2013, 07:30 ET Biocartis en Hospital del Mar (Barcelona-Spanje) bundelen krachten om diagnostische test voor darmkanker te ontwikkelen

Biocartis en Hospital del Mar kondigen vandaag hun licentieovereenkomst aan rond de biomerker EGFR voor darmkanker. Deze overeenkomst stelt...


05 Dec, 2012, 08:00 ET Biocartis Announces Commercial Launch of a New Biomarker Analysis Platform

Biocartis launches its revolutionary detection platform, Dynamic Multi-Analyte Technology ("DMAT"): - New proteomic and nucleic acid...


05 Dec, 2012, 08:00 ET Biocartis annonce la commercialisation d'une nouvelle plate-forme d'analyse des biomarqueurs

Biocartis lance sa plate-forme de détection révolutionnaire Dynamic Multi-Analyte Technology ('DMAT'): - La nouvelle...


30 Nov, 2011, 13:48 ET Biocartis Names Dr. Nayan Gregory Parekh As Chief Executive Officer

Current Ceo Rudi Pauwels Becomes Executive Chairman Focusing On Scientific And Technology Strategy New Ceo Appointment Strengthens...


17 Nov, 2011, 08:41 ET Biocartis Completes EUR 71 Million (USD 100 Million) Series C Fund Raising

Funds Will be Used to Commercialize a Fully Automated, Compact Molecular Diagnostics System Designed to Drive the Widespread Adoption of...


04 Nov, 2010, 13:00 ET bioMerieux and Biocartis Sign Strategic Partnership in Molecular Diagnostics

- Co-development of Assays and Co-distribution of a Fully Integrated Molecular Platform due for Launch in 2012 - bioMerieux Gains...


08 Apr, 2010, 04:42 ET Biocartis Raises EUR30 million in Series 'B' Financing Round

Biocartis SA, a biotech company active in the field of personalized medicine and focused on fast, multiplexed and fully integrated molecular...


15 Oct, 2009, 04:10 ET Biocartis Raises EUR10 Million in Series A Financing Round

Biocartis SA, a diagnostics company focused on fast and low-cost, integrated molecular and immunodiagnostics based on its proprietary...